Frontotemporal Dementia (FTD) is a neurodegenerative disease that affects two brain structures: the frontal lobes and the temporal lobes. The location of damage is distinct from that of Alzheimer’s Disease (AD), which is characterized by the degeneration of the brain structure known as the hippocampus. For each of these conditions, neurodegeneration can be readily quantified by the amount of shrinkage (loss of tissue) in these structures, which can be observed…READ MORE
The Latest
Recent News of Bruce Willis’s Frontotemporal Dementia Diagnosis Raises Questions About Available Treatments
March 6, 2023
PathGroup and uMETHOD Health Partner to Personalize Care for Mild Cognitive Impairment (MCI) and Early-stage Alzheimer’s Disease Patients
November 10, 2022
NASHVILLE, Tenn., Nov. 9, 2022 /PRNewswire/ -- uMETHOD Health, a health technology company specializing in precision medicine for complex diseases, announces a partnership with PathGroup, one of largest independent laboratories in the United States. uMETHOD's AI-based care planning solution, RestoreU, pairs comprehensive testing from PathGroup with actionable treatment recommendations, aimed at lowering patient's risk of developing Alzheimer's and disease progression in its early stages. Read the full release.…READ MORE
uMETHOD’s AI software helps doctors assess and reduce risk of falls among patients with cognitive decline
July 22, 2022
uMETHOD Health is a technology company in Research Triangle Park, North Carolina, focused on treating the causes of complex diseases. Its RestoreU METHOD uses patented artificial-intelligence (AI) software to identify the underlying factors that drive someone’s cognitive decline. This software generates personalized care plans on how to prevent, slow, or even roll-back the progression of cognitive decline. The software now identifies all the drugs someone may be taking that increase…READ MORE
Leading Alzheimer’s disease expert, Dr. Marwan Sabbagh describes how RestoreU optimizes brain health in Sonora Quest Webinar Series.
January 26, 2022
Dr. Marwan Sabbagh, an Alzheimer’s disease expert and geriatric neurologist at the Barrow Institute in Phoenix, AZ joined Rob Sherman, product manager at Sonora Quest to discuss how the health care community can help combat the rapid rise of Alzheimer's disease in Arizona using progressive and innovative solutions like RestoreU, offered by uMETHOD Health and Sonora Quest Laboratories. The conversation highlights Dr. Sabbagh's use of RestoreU to improve diagnostic confidence…READ MORE